Related Experiment Video
Updated: May 3, 2026
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
Not so WEE: targeting G₂/M to kill mesothelioma cells
1Department of Biochemistry and Molecular Biology; Massey Cancer Center; Virginia Commonwealth University; Richmond, VA USA.
Abstract:
It has been known for many years that manipulation of cell cycle checkpoint function represents one approach by which the toxicity of chemotherapy and of ionizing radiation can be increased in tumor cells. (1)(-) (3) In particular, abrogation of the G 2/M checkpoint has been shown to enhance the lethality of a wide range of toxic stresses. (1)(-) (3) Inhibition of the G 2/M checkpoint after chemotherapy/irradiation would result in tumor cells entering mitosis with damaged DNA, which would in turn result in loss of clonogenic survival (i.e., a lethal mitosis).
Insights
Targeting the G2/M cell cycle checkpoint enhances chemotherapy and radiation toxicity in tumor cells. Inhibiting this checkpoint causes cancer cells with damaged DNA to enter mitosis, leading to cell death.
Area of Science:
- Oncology
- Cell Biology
- Cancer Therapeutics
Background:
- Cell cycle checkpoints are critical for preventing proliferation of cells with damaged DNA.
- The G2/M checkpoint plays a key role in DNA damage response.
- Abrogation of checkpoints can sensitize tumor cells to cytotoxic agents.
Purpose of the Study:
- To investigate the role of G2/M checkpoint abrogation in enhancing tumor cell toxicity.
- To explore the mechanism by which G2/M inhibition leads to cell death.
Main Methods:
- Review of existing literature on cell cycle checkpoints and cancer therapy.
- Analysis of the consequences of G2/M checkpoint inhibition post-chemotherapy or irradiation.
Main Results:
- Inhibition of the G2/M checkpoint leads to tumor cells entering mitosis with unrepaired DNA.
- This premature entry into mitosis with damaged DNA results in a lethal event for cancer cells.
- Abrogation of the G2/M checkpoint significantly increases the lethality of various toxic stresses.
Conclusions:
- Targeting the G2/M checkpoint is a viable strategy to potentiate the efficacy of chemotherapy and radiation.
- Exploiting cell cycle regulation offers a promising avenue for improving cancer treatment outcomes.
